These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9178399

  • 1. Efficacy of misoprostol in the prophylaxis of gastroduodenal lesions induced by short-term nonsteroidal antiinflammatory drug therapy in elderly patients. A multicenter double-blind, placebo-controlled trial.
    Piette F, Teillet L, Naudin R, Boichut D, Capron MH.
    Rev Rhum Engl Ed; 1997 Apr; 64(4):259-66. PubMed ID: 9178399
    [Abstract] [Full Text] [Related]

  • 2. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
    Delmas PD, Lambert R, Capron MH.
    Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
    [Abstract] [Full Text] [Related]

  • 3. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
    Lanza FL, Kochman RL, Geis GS, Rack EM, Deysach LG.
    Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 6. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ, Karrasch JA, Szczepañski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND.
    N Engl J Med; 1998 Mar 12; 338(11):727-34. PubMed ID: 9494149
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G, Lazzaroni M, Petrillo M.
    Am J Gastroenterol; 1997 Apr 12; 92(4):663-7. PubMed ID: 9128319
    [Abstract] [Full Text] [Related]

  • 8. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG.
    J Rheumatol; 1998 Aug 12; 25(8):1602-11. PubMed ID: 9712107
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.
    Simon LS, Hatoum HT, Bittman RM, Archambault WT, Polisson RP.
    Fam Med; 1996 Mar 12; 28(3):204-10. PubMed ID: 8900554
    [Abstract] [Full Text] [Related]

  • 10. Misoprostol in the prevention of NSAID-induced gastric ulcer: a multicenter, double-blind, placebo-controlled trial.
    Roth SH.
    J Rheumatol Suppl; 1990 Feb 12; 20():20-4. PubMed ID: 2109073
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
    Emkey R, Rosenthal N, Wu SC, Jordan D, Kamin M, CAPSS-114 Study Group.
    J Rheumatol; 2004 Jan 12; 31(1):150-6. PubMed ID: 14705234
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
    Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A.
    Rev Rhum Engl Ed; 1997 Dec 12; 64(12):825-34. PubMed ID: 9476272
    [Abstract] [Full Text] [Related]

  • 13. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention.
    Rodríguez de la Serna A, Díaz-Rubio M.
    J Rheumatol; 1994 May 12; 21(5):927-33. PubMed ID: 8064736
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 12; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 15. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
    Lanza FL, Fakouhi D, Rubin A, Davis RE, Rack MF, Nissen C, Geis S.
    Am J Gastroenterol; 1989 Jun 12; 84(6):633-6. PubMed ID: 2499187
    [Abstract] [Full Text] [Related]

  • 16. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment].
    Martín de Argila C, Moreira V, Gisbert JP.
    An Med Interna; 1995 Feb 12; 12(2):85-96. PubMed ID: 7749017
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A.
    Clin Ther; 2007 Aug 12; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [Abstract] [Full Text] [Related]

  • 18. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb 12; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS, Stead H, Wallemark CB, Nicholson PA.
    J Rheumatol Suppl; 1991 Mar 12; 28():11-4. PubMed ID: 1903808
    [Abstract] [Full Text] [Related]

  • 20. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL, Stock KP, Hüdepohl M.
    Z Rheumatol; 1991 Mar 12; 50(3):175-80. PubMed ID: 1927064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.